Fulgent Genetics (FLGT) Income from Continuing Operations (2015 - 2026)
Fulgent Genetics (FLGT) posted Income from Continuing Operations of 25278000.0 for Q1 2026, down 168.37% sequentially from 36975000.0 in Q4 2025, and down 112.01% YoY from 210467593.58 in Q1 2025.
Fulgent Genetics (FLGT) Income from Continuing Operations (2015 - 2026) Analysis & Trends
Fulgent Genetics (FLGT) has 12 years of Income from Continuing Operations data on file, last reported at 25278000.0 in Q1 2026.
- Quarterly Income from Continuing Operations fell 112.01% year-over-year to 25278000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 14331000.0 (up 61.01% YoY) and the FY2025 annual result came in at 1006000.0, up 97.4% from the prior year.
- Income from Continuing Operations slipped to 25278000.0 in Q1 2026 per FLGT's latest filing, from 36975000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 153557000.0 in Q1 2022, with the low at 25278000.0 in Q1 2026.
- Average Income from Continuing Operations over 5 years is 3569588.24, with a median of 11600000.0 recorded in 2023.
- Year-over-year, Income from Continuing Operations slumped 1100.74% in 2023 and jumped 3631.52% in 2025.
- Fulgent Genetics' Income from Continuing Operations stood at 24076000.0 in 2022, then soared by 202.09% to 24580000.0 in 2023, then plunged by 104.26% to 1047000.0 in 2024, then jumped by 3631.52% to 36975000.0 in 2025, then plunged by 168.37% to 25278000.0 in 2026.
- Business Quant data shows FLGT's Income from Continuing Operations at 25278000.0 in Q1 2026, 36975000.0 in Q4 2025, and 6809000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -85.11 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 339.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 269.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Fulgent Genetics | 642.94 Mn | 360.99 Mn | 21.49 Mn | -25.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.28 Mn |
| Dec 31, 2025 | 36.98 Mn |
| Sep 30, 2025 | -6.81 Mn |
| Jun 30, 2025 | -19.22 Mn |
| Mar 31, 2025 | -11.92 Mn |
| Dec 31, 2024 | -1.05 Mn |
| Sep 30, 2024 | -14.69 Mn |
| Jun 30, 2024 | -9.09 Mn |
| Mar 31, 2024 | -13.85 Mn |
| Dec 31, 2023 | 24.58 Mn |
| Sep 30, 2023 | -13.44 Mn |
| Jun 30, 2023 | -11.60 Mn |
| Mar 31, 2023 | -15.85 Mn |
| Dec 31, 2022 | -24.08 Mn |
| Sep 30, 2022 | 1.34 Mn |
| Jun 30, 2022 | 11.10 Mn |
| Mar 31, 2022 | 153.56 Mn |
| Dec 31, 2021 | 103.68 Mn |
| Sep 30, 2021 | 122.22 Mn |
| Jun 30, 2021 | 75.91 Mn |